These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28825467)

  • 1. Parallel Chemistry Approach to Identify Novel Nuclear Receptor Ligands Based on the GW0742 Scaffold.
    Teske KA; Rai G; Nandhikonda P; Sidhu PS; Feleke B; Simeonov A; Yasgar A; Jadhav A; Maloney DJ; Arnold LA
    ACS Comb Sci; 2017 Oct; 19(10):646-656. PubMed ID: 28825467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferation-activated receptor δ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor.
    Nandhikonda P; Yasgar A; Baranowski AM; Sidhu PS; McCallum MM; Pawlak AJ; Teske K; Feleke B; Yuan NY; Kevin C; Bikle DD; Ayers SD; Webb P; Rai G; Simeonov A; Jadhav A; Maloney D; Arnold LA
    Biochemistry; 2013 Jun; 52(24):4193-203. PubMed ID: 23713684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel VDR antagonists based on the GW0742 scaffold.
    Teske KA; Bogart JW; Arnold LA
    Bioorg Med Chem Lett; 2018 Feb; 28(3):351-354. PubMed ID: 29287957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into human peroxisome proliferator activated receptor delta (PPAR-delta) selective ligand binding.
    Batista FA; Trivella DB; Bernardes A; Gratieri J; Oliveira PS; Figueira AC; Webb P; Polikarpov I
    PLoS One; 2012; 7(5):e33643. PubMed ID: 22606221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity.
    Sznaidman ML; Haffner CD; Maloney PR; Fivush A; Chao E; Goreham D; Sierra ML; LeGrumelec C; Xu HE; Montana VG; Lambert MH; Willson TM; Oliver WR; Sternbach DD
    Bioorg Med Chem Lett; 2003 May; 13(9):1517-21. PubMed ID: 12699745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Transcription mediated by the Vitamin D Receptor and the Peroxisome Proliferator-Activated Receptor δ in the presence of GW0742 analogs.
    Teske K; Nandhikonda P; Bogart JW; Feleke B; Sidhu P; Yuan N; Preston J; Goy R; Arnold LA
    J Biomol Res Ther; 2014; 3(1):. PubMed ID: 25485183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery.
    Perez Diaz N; Lione LA; Hutter V; Mackenzie LS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
    Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
    J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GW0742 activates peroxisome proliferator-activated receptor δ to reduce free radicals and alleviate cardiac hypertrophy induced by hyperglycemia in cultured H9c2 cells.
    Cheng KC; Chang WT; Li Y; Cheng YZ; Cheng JT; Chen ZC
    J Cell Biochem; 2018 Nov; 119(11):9532-9542. PubMed ID: 30129179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Structural Optimization of Dual FXR/PPARδ Activators.
    Schierle S; Neumann S; Heitel P; Willems S; Kaiser A; Pollinger J; Merk D
    J Med Chem; 2020 Aug; 63(15):8369-8379. PubMed ID: 32687365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urine.
    Sobolevsky T; Dikunets M; Sukhanova I; Virus E; Rodchenkov G
    Drug Test Anal; 2012 Oct; 4(10):754-60. PubMed ID: 22977012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of highly potent and selective benzyloxybenzyl-based peroxisome proliferator-activator receptor (PPAR) delta agonists.
    Bratton LD; Filzen GF; Geyer A; Hoffman JK; Lu G; Pulaski J; Trivedi BK; Unangst PC; Xu X
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3624-9. PubMed ID: 17498950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists.
    Epple R; Cow C; Xie Y; Azimioara M; Russo R; Wang X; Wityak J; Karanewsky DS; Tuntland T; Nguyêñ-Trân VT; Cuc Ngo C; Huang D; Saez E; Spalding T; Gerken A; Iskandar M; Seidel HM; Tian SS
    J Med Chem; 2010 Jan; 53(1):77-105. PubMed ID: 19928766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of PPARδ Agonists That Promote Osteogenesis in a Human Mesenchymal Stem Cell Culture and in a Mouse Model of Human Osteoporosis.
    Kress BJ; Kim DH; Mayo JR; Farris JT; Heck B; Sarver JG; Andy D; Trendel JA; Heck BE; Erhardt PW
    J Med Chem; 2021 May; 64(10):6996-7032. PubMed ID: 33988379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists.
    Maltarollo VG; Togashi M; Nascimento AS; Honorio KM
    PLoS One; 2015; 10(3):e0118790. PubMed ID: 25767888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis.
    Polak PE; Kalinin S; Dello Russo C; Gavrilyuk V; Sharp A; Peters JM; Richardson J; Willson TM; Weinberg G; Feinstein DL
    J Neuroimmunol; 2005 Nov; 168(1-2):65-75. PubMed ID: 16098614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand- and structure-based drug design strategies and PPARδ/α selectivity.
    Maltarollo VG; Honório KM
    Chem Biol Drug Des; 2012 Oct; 80(4):533-44. PubMed ID: 22672760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of the ligand-binding domain of human peroxisome proliferator-activated receptor δ in complexes with phenylpropanoic acid derivatives and a pyridine carboxylic acid derivative.
    Oyama T; Takiguchi K; Miyachi H
    Acta Crystallogr F Struct Biol Commun; 2022 Feb; 78(Pt 2):81-87. PubMed ID: 35102897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor {delta} regulates inflammation via NF-{kappa}B signaling in polymicrobial sepsis.
    Zingarelli B; Piraino G; Hake PW; O'Connor M; Denenberg A; Fan H; Cook JA
    Am J Pathol; 2010 Oct; 177(4):1834-47. PubMed ID: 20709805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.